| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | +64.2% |
| Cost of Revenue | $2.1M | +70.1% |
| R&D Expense | $30.4M | -63.9% |
| SG&A Expense | $34.5M | -58.6% |
| Operating Income | -$67.2M | +60.9% |
| Interest Expense | $14.7M | +10.1% |
| Income Tax | $0 | — |
| Net Income | -$59.6M | +66.7% |
| EPS (Basic) | -$23.51 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.9M | -54.2% |
| Accounts Receivable | $131K | +84.5% |
| Inventory | $679K | -65.9% |
| Current Assets | $37.4M | -48.2% |
| Total Assets | $38.3M | -48.0% |
| Current Liabilities | $22.2M | -18.5% |
| Long-term Debt | $102.5M | +1.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.0M | +53.5% |
| Capital Expenditures | $20K | +0.0% |
| Investing Cash Flow | -$20K | +0.0% |
| Financing Cash Flow | $36.7M | +38.2% |
| Free Cash Flow | -$72.0M | +53.5% |
| -282.3% |
| EPS (Diluted) | -$23.51 | -282.3% |
| Total Liabilities |
| $131.4M |
| +0.9% |
| Stockholders' Equity | -$93.1M | -64.8% |